All filters
Slidesets
New indicators for the evaluation of hepatitis B therapy- Xinxin Zhang, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Sequential cross-section study on hepatitis viruses infection in Chinese AIDS patients- Lin Liu, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Non-alcoholic fatty liver disease in China- Jiangao Fan, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Videos
Micro-elimination as a strategy to reach global elimination | Jeffrey Lazarus, PhD, MIH, MA
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
Prevention transmission strategies through strengthening the health system | Maia Butshashvili, MD, MS, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
Prevention transmission strategies prior to infection - Incarceration | Lara Strick, MD, MS
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
Prevention transmission strategies prior to infection - People who inject drugs | Diana Sylvestre, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
How to measure your success; globally and locally | Yvan Hutin, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
Real-life experiences - Egypt | Imam Waked, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
WHO status report: Global response to the strategic framework | Yvan Hutin, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
Setting the stage - Key challenges in elimination | Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Videos
Aramchol for NASH and beyond: From scientific rationale to clinical development | Carol Brosgart
Presented at:
HEP DART 2017
Videos
The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations | Manal El-Sayed, MD, PhD
Presented at:
HEP DART 2017
Videos
The Re-vival of Bile Acid Based Therapeutics for Children and Adults | Saul Karpen
Presented at:
HEP DART 2017
Videos
NASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes | Arun Sanyal
Presented at:
HEP DART 2017
Videos
Looking back to move forward: designing next-gen RNAi for best results in HBV | Bruce Given
Presented at:
HEP DART 2017
Videos
HEV Update: Diagnostics and Management | Kenneth Sherman, MD, PhD
Presented at:
HEP DART 2017
Videos
Revisiting the Molecular and Cell Biology of the Hepatitis B Virus Towards Elimination | Fabien Zoulim, MD, PhD
Presented at:
HEP DART 2017
Videos
Pan-genotypic direct-acting antiviral agents: Opportunity to achieve HCV elimination | Tarik Asselah
Presented at:
HEP DART 2017
Videos
DAA Controversies: Do they Cause HBV Reactivation and/or HCC? | Jordan Feld, MD, MPH
Presented at:
HEP DART 2017